Toxaphene


Curated chemical-gene interactions from CTD
Entrez gene IDGene symbolInteraction typeReference
10124 ARL4A Decreases expression PMID:23153324
1026 CDKN1A Decreases expression PMID:12473173
10277 UBE4B Increases expression PMID:23153324
10512 SEMA3C Decreases expression PMID:23153324
121227 LRIG3 Increases expression PMID:23153324
1281 COL3A1 Increases expression PMID:23153324
13088 CYP2B10 Increases expression PMID:26187448; PMID:28218408
13094 CYP2B9 Increases expression PMID:28218408
13112 CYP3A11 Increases expression PMID:26187448; PMID:28218408
143686 SESN3 Increases expression PMID:23153324
1543 CYP1A1 Increases expression PMID:26187448; PMID:28218408
1544 CYP1A2 Increases expression PMID:26187448; PMID:28218408
1588 CYP19A1 Decreases activity PMID:16996190
1675 CFD Decreases expression PMID:23153324
1843 DUSP1 Decreases expression PMID:23153324
197257 LDHD Decreases expression PMID:1269500
2099 ESR1 Increases activity PMID:10774817; PMID:11356845; PMID:16626760; PMID:26022396; PMID:9860891
2099 ESR1 Increases expression PMID:21295777
2100 ESR2 Increases activity PMID:16626760; PMID:9860891
2101 ESRRA Affects activity PMID:10493499; PMID:11356845; PMID:11356845; PMID:11850205; PMID:15955695
23503 ZFYVE26 Increases expression PMID:23153324
23650 TRIM29 Decreases expression PMID:23153324
25948 KBTBD2 Decreases expression PMID:23153324
26118 WSB1 Decreases expression PMID:23153324
2697 GJA1 Decreases expression PMID:8820588
3014 H2AX Decreases expression PMID:23153324
367 AR Increases activity PMID:10696776
3835 KIF22 Decreases expression PMID:23153324
3939 LDHA Increases expression PMID:1269500
3945 LDHB Increases expression PMID:1269500
3948 LDHC Increases expression PMID:1269500
43 ACHE Decreases activity PMID:8262581
4837 NNMT Decreases expression PMID:23153324
5241 PGR Increases expression PMID:10774817
53349 ZFYVE1 Increases expression PMID:23153324
54662 TBC1D13 Increases expression PMID:23153324
54793 KCTD9 Decreases expression PMID:23153324
55143 CDCA8 Decreases expression PMID:23153324
55327 LIN7C Increases expression PMID:23153324
5617 PRL Increases expression PMID:12804517
56894 AGPAT3 Increases expression PMID:23153324
5834 PYGB Decreases expression PMID:23153324
5925 RB1 Decreases expression PMID:10048758
672 BRCA1 Increases expression PMID:12473173
7031 TFF1 Affects expression PMID:12473173; PMID:9276643
7252 TSHB Increases expression PMID:8933632
7538 ZFP36 Decreases expression PMID:23153324
7871 SLMAP Decreases expression PMID:23153324
81617 CAB39L Decreases expression PMID:23153324
83871 RAB34 Decreases expression PMID:23153324
84068 SLC10A7 Increases expression PMID:23153324
84617 TUBB6 Decreases expression PMID:23153324
84662 GLIS2 Decreases expression PMID:23153324
8856 NR1I2 Increases activity PMID:16565514; PMID:25680588
9212 AURKB Decreases expression PMID:23153324
9725 TMEM63A Increases expression PMID:23153324

DISCLAIMER

We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.